Donor polymorphism of tumor necrosis factor gene: Relationship with variable severity of hepatitis C recurrence after liver transplantation

Transplantation

Volumn 68, Issue 12, 1999, Pages 1898-1902

  Rosen, Hugo R ^a,b   Lentz, Jennifer J ^c   Rose, Steven L ^c   Rabkin, John ^d   Corless, Christopher L ^a   Taylor, Kent ^e   Chou, Sunwen ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon Health Sciences   (United States)

^c Prometheus Laboratories   (United States)

^d PORTLAND VA MEDICAL CENTER   (United States)

^e CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

CLINICAL ARTICLE; CONFERENCE PAPER; DISEASE SEVERITY; GENE AMPLIFICATION; GENE LOCUS; GENETIC POLYMORPHISM; HEPATITIS C; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; NUCLEOTIDE SEQUENCE; ORGAN DONOR; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0033611143     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199912270-00014     Document Type: Conference Paper

References (43)

1. DiBisceglie AM. Liver transplantation for hepatitis C: the promise and the challenge. Hepatology 1995; 22: 660.
2. Rosen HR, Shackleton CR, Higa L, et al. Use of OKT3 associated with early and severe hepatitis C recurrence following liver transplantation. Am J Gastroenterol 1997; 92(9): 1453.
3. Zhou S, Terrault NA, Ferrell L, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. Hepatology 1996; 24: 1041.
4. Eugster HP, Muller M, Karrer U, et al. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-α double deficient mice. Int Immunol 1996; 8: 23.
5. Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995; 21: 1304.
6. Marinos G, Naoumov NV, Rossol S, et al. Tumor necrosis factor receptors in patients which chronic hepatitis B virus infection. Gastroenterology 1995; 108: 1453.
7. Coletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion in the rat. J Clin Invest 1990; 85: 1936.
8. Larrea E, Garcia N, Qian C, Civeira MP, Prieto J. Tumor necrosis factor a gene expression and the response to interferon in chronic hepatitis C. Hepatology 1996; 23: 210.
9. Gane E, Williams R, Naoumov N. Immunopathogenic mechanisms in HCV recurrence post-liver transplantation (in press).
10. Webb GC, Chaplin DD. Genetic variability at the human tumor necrosis factor loci. J Immunol 1990; 145: 1278.
11. Wilson AG, Di Giovine FS, Blakemore AI, Duff GW. Single base change in the human tumor necrosis factor alpha gene detectable by NcoI restriction of PCR product. Human Molec Genetics 1992; 1: 353.
12. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant amino acid in position 26 and a reduced level of TNF-b production. J Exp Med 1991; 173: 209.
13. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195.
14. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557.
15. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996; 2: 405.
16. Gretch DR, Lee W, Corey L. Use of aminotransferase, hepatitis C antibody, and hepatitis C polymerase chain reaction RNA assays to establish the diagnosis of hepatitis C virus infection in a diagnostic virology laboratory. J Clin Microbiol 1992; 30: 2145.
17. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696.
18. Cabrera M, Shaw M-A, Sharples C. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1529.
19. Nedospasov SA, Udalova IA, Kuprash DV, Turetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. J Immunol 1991; 147: 1053.
20. Rosen HR, Hinrichs DJ, Gretch DR, et al. Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 1999; 117: 926.
21. Rosen HR, Gretch DR, Oehlke M, et al. Timing and severity of hepatitis C recurrence following liver transplantation as predictors of long-term allograft injury. Transplantation 1998; 65: 1178.
22. Schluger LK, Sheiner PA, Thung N, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971.
23. Kock A, Schwarz T, Kirnbauer R, et al. Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990; 172: 1609.
24. Gonzalez-Amaro R, Garcia-Monzon C, et al. Induction of tumor necrosis factor α production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994; 179: 841.
25. Fukumota T, Berg T, Ku YK, et al. Viral dynamics of hepatitis C early after liver transplantation: evidence for rapid turnover of serum virions. Hepatology 1996; 24: 1351.
26. Abrignani S. Bystander activation by cytokines of intrahepatic T cells in chronic viral hepatitis. Semin Liver Dis 1997; 17: 319.
27. Folks TM, Couse KA, Justement J, et al. Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 1989; 86: 2365.
28. Gane EJ, Naoumov NK, Qian KP, et al. A longitudinal analysis of hepatitis C replication following liver transplantation. Gastroenterology 1996; 110: 167.
29. Doughty AL, Spencer JD, Cossart YE, McCaughan GW. Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels. Liver Transplant Surg 1998; 4: 15.
30. DiMartino V, Saurini F, Samuel D, et al. Longitudinal study of intrahepatic HCV replication after liver transplantation. Hepatology 1997; 26: 1343.
31. Lau JYN, Xie X, Lai MMC, Wu PC. Apoptosis and viral hepatitis. Semin Liver Dis 1998; 18: 169.
32. Tannapfel A, Kohlhaw K, Ebelt J, et al. Apoptosis and the expression of Fas and Fas ligand (FasL) antigen in rejection and reinfection in liver allograft specimens. Transplantation 1999; 67: 1079.
33. Vos T, Havings R, Gouw AS, Kuipers F, Jansen PL, Moshage H. Differential effects of nitric oxide (NO) synthesis inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 1997; 113: 1323.
34. Drouet C, Shakov AN, Jongeneel CV. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-a promoter in primary macrophages. J Immunol 1991; 147: 1694.
35. Wilson AG. Genetics of tumor necrosis factor (TNF) in autoimmune liver diseases: red hot or red herring? J Hepatol 1999; 30: 331.
36. Warzocha K, Ribeiro P, Bienvenu J, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 1998; 91: 3574.
37. Booy R, Nadel S, Hibberd M, Levin M, Newport MJ. Genetic influence on cytokine production in meningococcal disease. Lancet 1997; 349: 1176.
38. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Dwiatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508.
39. Hohler T, Kruger A, Gerken G, Schneider PM, Buschenfelde K-HM, Rittner C. Tumor necrosis factor α promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol 1998; 54: 173.
40. Grove J, Daly AK, Bassendine MG, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997; 26: 143.
41. Plevy SE, Targan SR, Yang H, Fernandez D, Rotter JI, Toyoda H. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996; 110: 1053.
42. Wilhelmsen KC. Does tumor necrosis factor play a role in alcoholic steatohepatitis? The potential pitfalls of a case-controlled allelic association analysis. Hepatology 1997; 26: 232.
43. Scallion BJ, Moore MA, Trinh H, Knight DM, Ghrayeb J. Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions. Cytokine 1995; 7: 251.